Oral administration of the vasopressin V2-receptor antagonist tolvaptan is safe and effective for the treatment of chronic hyponatremia in the long term, according to the results of the SALTWATER ...

axis and peripheral tissues such as the mammary gland, uterus, ovary and kidney. Key receptors being studied are the vasopressin and oxytocin receptors, novel oestrogen receptor GPR30, and the ...